EWA
ZYME icon

EverSource Wealth Advisors’s Zymeworks ZYME Stock Holding History

EverSource Wealth Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89K Sell
187
-31
-14% -$788 ﹤0.01% 3287
2026
Q1 		$5.46K Buy
218
+36
+20% +$852 ﹤0.01% 3229
2025
Q4 		$4.79K Hold
182
– – ﹤0.01% 3143
2025
Q3 		$3.11K Buy
182
+1
+0.6% +$14 ﹤0.01% 3352
2025
Q2 		$2.27K Buy
181
+168
+1,292% +$2K ﹤0.01% 3469
2025
Q1 		$155 Buy
13
+3
+30% +$41 ﹤0.01% 3746
2024
Q4 		$146 Buy
+10
New +$140 ﹤0.01% 3488

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

EverSource Wealth Advisors's ZYME Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Zymeworks (ZYME) stake by 14% in Q2 2026, selling an estimated $788 and leaving 187 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

EverSource Wealth Advisors first reported a position in ZYME in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.46K in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • EverSource Wealth Advisors held 187 shares of Zymeworks worth $4.89K as of Q2 2026.
  • EverSource Wealth Advisors sold 31 Zymeworks shares in Q2 2026, an estimated $788.
  • Zymeworks made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3287 holding.
  • EverSource Wealth Advisors first reported a position in Zymeworks in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Zymeworks position peaked at $5.46K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.